Skip to content

Optimization of intravenous vancomycin treatment schedule for pediatric population with Monte Carlo Simulation

Optimization of intravenous vancomycin treatment schedule for pediatric population with Monte Carlo Simulation - Optimization of intravenous vancomycin treatment schedule for pediatric population with Monte Carlo Simulation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000022343
Enrollment
100
Registered
2016-05-19
Start date
2016-05-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients under 18 years old who were administered intravenous vancomycin in Department of Pediatrics or Department of Pediatric Cardiology in our institute between April 1st 2011 and March 31st 2016.

Interventions

None listed

Sponsors

Department of Pediatrics, Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who were administered intravenous vancomycin in Department of Pediatrics or Department of Pediatric Cardiology between April 1st 2011 and March 31st 2016. Age under 18 years when vancomycin was initiated. Written informed consent is obtained.

Exclusion criteria

Exclusion criteria: Patients with renal dysfunction. Data unavailability exists. Lack of informed consent.

Design outcomes

Primary

MeasureTime frame
The proportion of the patients who achieved more than 400 of AUC/MIC in the present treatment strategy in our institute.

Secondary

MeasureTime frame
To compare the duration required for body temperature to be normalized between the populations with AUC/MIC above 400 and below 400. With Monte Carlo simulation, we will optimize the treatment strategy of vancomycin so that more than 90% of the patients achieve AUC/MIC more than 400.

Countries

Japan

Contacts

Public ContactReo Tanoshima

Yokohama City University Department of Pediatrics

tanotch@yokohama-cu.ac.jp(+81)45-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026